Evidence map›Paper›PMID 31623362›Full record

ArticleInternational journal of molecular sciences2019

Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways.

Annunziatina Laurino, Valentina Spinelli, Manuela Gencarelli, Valentina Balducci, Leonardo Dini, Lorenzo Diolaiuti, Marco Ghionzoli, Antonio Messineo, Alessandro Mugelli, Elisabetta Cerbai and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.Clinical science (London, England : 1979) · 2020
    Review
  11. Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Annunziatina LaurinoDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. annunziatina.laurino@unifi.it.
Valentina SpinelliDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. valentina.spinelli@unifi.it.
Manuela GencarelliDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. manuela.gencarelli@unifi.it.
Valentina BalducciDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. valentina.balducci@unifi.it.
Leonardo DiniDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. dini.leonardo88@gmail.com.
Lorenzo DiolaiutiDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. lorenzod88@live.it.
Marco GhionzoliDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. marco.ghionzoli@meyer.it.
Antonio MessineoDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. antonio.messineo@meyer.it.
Alessandro MugelliDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. alessandro.mugelli@unifi.it.
Elisabetta CerbaiDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. elisabetta.cerbai@unifi.it.
Laura RaimondiDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. laura.raimondi@unifi.it.
Laura SartianiDepartment of NEUROFARBA, Center of Molecular Medicine, University of Firenze, 50139 Firenze, Italy. laura.sartiani@unifi.it.ORCID 0000-0002-4208-0913
University of Florence · ITMeyer Children's Hospital · IT

Funding

Fondazione CR Firenze Grant 2017-2018M.I.U.R. PRIN 2012 2012227FLF_002University Grant for Research Activity Grant 2016-2018
6 · The paper itself

Abstract

Skeletal muscle regeneration is ensured by satellite cells (SC), which upon activation undergo self-renewal and myogenesis. The correct sequence of healing events may be offset by inflammatory and/or fibrotic factors able to promote fibrosis and consequent muscle wasting. Angiotensin-II (Ang) is an effector peptide of the renin angiotensin system (RAS), of which the direct role in human SCs (hSCs) is still controversial. Based on the hypertrophic and fibrogenic effects of Ang via transient receptor potential canonical (TRPC) channels in cardiac and renal tissues, we hypothesized a similar axis in hSCs. Toward this aim, we demonstrated that hSCs respond to acute Ang stimulation, dose-dependently enhancing p-mTOR, p-AKT, p-ERK1/2 and p-P38. Additionally, sub-acute Ang conditioning increased cell size and promoted trans-differentiation into myofibroblasts. To provide a mechanistic hypothesis on TRPC channel involvement in the processes, we proved that TRPC channels mediate a basal calcium entry into hSCs that is stimulated by acute Ang and strongly amplified by sub-chronic Ang conditioning. Altogether, these findings demonstrate that Ang induces a fate shift of hSCs into myofibroblasts and provide a basis to support a benefit of RAS and TRPC channel blockade to oppose muscle fibrosis.

Indexed as

Cell TransdifferentiationSignal TransductionAngiotensin IICalcium SignalingCell SurvivalHumansHypertrophyMolecular ImagingMyoblastsMyofibroblastsRenin-Angiotensin SystemSatellite Cells, Skeletal MuscleAngiotensin IIangiotensinCa2+ signalinghypertrophymyofibroblastmyogenesissatellite cellsskeletal muscleTRPC channels

Identifiers

PMID31623362
PMCPMC6801484
OpenAlexW2977909961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.